1. Home
  2. JF vs DARE Comparison

JF vs DARE Comparison

Compare JF & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JF

J and Friends Holdings Limited American Depositary Shares

HOLD

Current Price

$0.91

Market Cap

17.4M

Sector

N/A

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$0.64

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JF
DARE
Founded
2012
2015
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
16.6M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
JF
DARE
Price
$0.91
$0.64
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
4.6K
★ 170.7K
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,807,885.00
Revenue This Year
N/A
$163.80
Revenue Next Year
N/A
$226.14
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.81
$0.67
52 Week High
$1.19
$3.78

Technical Indicators

Market Signals
Indicator
JF
DARE
Relative Strength Index (RSI) 43.80 27.37
Support Level $0.90 N/A
Resistance Level $1.02 $0.88
Average True Range (ATR) 0.03 0.04
MACD -0.00 -0.01
Stochastic Oscillator 9.09 2.39

Price Performance

Historical Comparison
JF
DARE

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd providing merchant digitalization and commerce-enablement solutions to small and medium enterprises (SME). Its solutions feature critical functionality that SMEs need to engage with consumers, manage their operations, accept payments, and grow their business. Such solutions empower single- and multi-location retailers, restaurants, and other SMEs to compete successfully in an omni-channel market environment by engaging with consumers across online, mobile, and physical channels. The group conducts all of its current operations in Australia and generates revenues from continuing operations are derived from within Australia.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: